US senator slams Allergan patent deal with Native-American tribe Ruby Khatun Khatun18 Sept 2017 9:31 AM ISTUS Senator Sherrod Brown said on Friday a deal that drugmaker Allergan Plc made with a Native-American tribe to shield patents “rips off consumers”...
Tesaro ovarian cancer drug gets EU agency backing Ruby Khatun Khatun18 Sept 2017 9:15 AM ISTA European Medicines Agency (EMA) panel recommended the approval of Tesaro Inc’s key drug, niraparib, for the treatment of recurrent ovarian...
CDSCO declares certain blood grouping serums NOT OF STANDARD QUALITY Ruby Khatun Khatun17 Sept 2017 11:58 AM ISTNew Delhi: Through a recent notification, Central Drugs Standard Control Organisation, Directorate General of Health Services, Ministry of Health...
Zydus Cadila gets USFDA nod for two drugs Ruby Khatun Khatun17 Sept 2017 10:24 AM ISTNew Delhi: Drug firm Zydus Cadila on Friday said it has received approval from the US health regulator for its Modafinil and Solifenacin Succinate...
Teva to sell womens health assets to CVC Capital Partners: report Ruby Khatun Khatun17 Sept 2017 10:14 AM ISTTeva Pharmaceutical Industries Ltd is close to a deal to sell its women’s health assets outside the United States to private equity firm CVC Capital...
Astrazeneca Farxiga results may open up type 1 diabetes opportunity Ruby Khatun Khatun17 Sept 2017 9:57 AM ISTFRANKFURT: AstraZeneca’s Farxiga was shown to help type-1 diabetics when added to standard insulin therapy, possibly opening up an additional market...
Pfizer, Astellas prostate cancer drug promising in late-stage trial Ruby Khatun Khatun17 Sept 2017 9:35 AM ISTPfizer Inc and Japan’s Astellas Pharma Inc said on Thursday their blockbuster prostate cancer drug met the main goal of a key study that tested it for...
Moderna, AstraZeneca heart drug succeeds early-stage trial Ruby Khatun Khatun17 Sept 2017 9:15 AM ISTBiotech unicorn Moderna Therapeutics said on Thursday its heart drug, developed along with British drugmaker AstraZeneca met the main goal in an...
Amgen gets FDA approval for Mvasi- first biosimilar to treat cancer Ruby Khatun Khatun16 Sept 2017 10:53 AM ISTThe U.S. Food and Drug Administration (FDA) approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple...
Aspen to buy remaining AstraZeneca anaesthetic rights for up to 766 million dollar Ruby Khatun Khatun16 Sept 2017 10:17 AM ISTLONDON: AstraZeneca said on Thursday it had agreed to sell the U.S. rights to a portfolio of anaesthetics to South Africa's Aspen Group for up to $766...
Halozyme to license drug delivery tech to Roche, Bristol-Myers Ruby Khatun Khatun16 Sept 2017 9:55 AM ISTU.S. drugmaker Halozyme Therapeutics Inc said on Thursday it would license its drug delivery technology to Bristol-Myers Squibb Co and Swiss drugmaker...
Challenge of Allergan tribal patent deal in uncharted legal territory Ruby Khatun Khatun16 Sept 2017 9:35 AM ISTAs generic drug manufacturers are gearing up to argue that a deal Allergan Plc made with a Native American tribe to shield patents from administrative...
